Welcome to Sott.net
Thu, 04 Nov 2021
The World for People who Think

Health & Wellness
Map

Attention

"Proceed with caution at your own peril' Merck's COVID 'super drug' poses serious health risks, scientists warn

Tyler Durden
Zero Hedge
Fri, 08 Oct 2021 09:56 UTC
molnupiravir
© Unknown
COVID drug molnupiravir
As it turns out, all the scientists and doctors who insisted that Merck's "revolutionary" COVID drug molnupiravir is extremely safe weren't faithfully adhering to "the science" after all. Because according to a report published Thursday by Barron's, some scientists are worried that the drug - which purportedly cut hospitalizations in half during a study that was cut short - could cause cancer or birth defects.

So much for having a "strong safety profile," as Dr. Scott Gottlieb claimed in an interview on the day Merck first publicized the research.

It's perfectly understandable why Merck might choose to play down this safety risk: assuming it's approved, the drug is widely expected to be one of "the most lucrative drugs ever" - which is one reason why Merck's shares soared into double-digit territory after the announcement.

As we reported earlier this week, Merck and its "partner" Ridgeback Biotherapeutics will profit immensely by charging customers up to 40x what it costs to make the drug, which Ridgeback originally licensed from Emory University for an "undisclosed sum". The drug was developed with funding from the federal government.

According to Barron's, some scientists who have studied the drug believe that its method of suppressing the virus could potentially run amok within the body.

Comment: This is just one more quick fix money-maker where-in profits would cover/cover-up any potential lawsuits.

      Read More...
Magnify

Covid-19 infection may prompt Guillain-Barré syndrome, J&J vaccine implicated in increased risk

Zakiyah Ebrahim
News 24
Fri, 08 Oct 2021 09:27 UTC
coronavirus
© UC San Francisco
An electron microscopy image of a cell infected by the coronavirus that causes COVID-19.
What are breakthrough infections?

Covid-19 infection may occasionally trigger Guillain-Barré syndrome, a rare but potentially serious neurological condition, according to new research appearing in the journal Brain, and published by Oxford University Press.

Guillain-Barré syndrome is an autoimmune neurological disorder where the body's immune system begins to attack the body itself and damage nerve cells. It can cause muscle weakness and occasionally paralysis.

Comment: Coronavirus itself has been found to have a very unusual make up, which, along with its other unusual effects on the body, including an increased risk of delirium, has led numerous researchers to conclude that it was engineered in a laboratory:

      Read More...
Whistle

Top trans doctors blowing the whistle on 'sloppy' care

Abigail Shrier
bariweiss.substack.com
Mon, 04 Oct 2021 17:55 UTC
transgender surgery
© Glenn Asakawa/The Denver Post via Getty Images
Dr. Marci Bowers performs gender reassignment surgery in Trinadad’s Mount San Rafael Hospital.
In exclusive interviews, two prominent providers sound off on puberty blockers, 'affirmative' care, the inhibition of sexual pleasure, and the suppression of dissent in their field.

For nearly a decade, the vanguard of the transgender-rights movement — doctors, activists, celebrities and transgender influencers — has defined the boundaries of the new orthodoxy surrounding transgender medical care: What's true, what's false, which questions can and cannot be asked.

They said it was perfectly safe to give children as young as nine puberty blockers and insisted that the effects of those blockers were "fully reversible." They said that it was the job of medical professionals to help minors to transition. They said it was not their job to question the wisdom of transitioning, and that anyone who did — including parents — was probably transphobic. They said that any worries about a social contagion among teen girls was nonsense. And they never said anything about the distinct possibility that blocking puberty, coupled with cross-sex hormones, could inhibit a normal sex life.

Comment: Detrans woman regrets mastectomy: 'Don't indulge young people who think they're trans - many are mentally ill'

      Read More...
Stock Down

Immunity weakens faster in men than women within months of Pfizer's second shot, study finds

Alisa Odenheimer and Robert Langreth
Calgary Herald
Thu, 07 Oct 2021 18:24 UTC
Pfizer vaccine
© ANDREJ IVANOV / Bloomberg
A cyclist receives a dose of the Pfizer-BioNTech COVID-19 vaccine at the Gilles Villeneuve racetrack in Montreal, on Saturday, May 29, 2021.
Immunity provided by the COVID-19 vaccine from partners Pfizer Inc. and BioNTech SE weakens significantly within months, with men having less protection than women, according to research that supports the use of booster doses.

Protective antibodies decreased continuously during the six months after the administration of the second dose of the vaccine, according to a study of about 5,000 Israeli health workers, published Wednesday in the New England Journal of Medicine. The levels fell first at a sharp pace and later at a more moderate one.

Researchers worldwide are trying to identify the critical threshold of antibodies needed to prevent coronavirus infection, severe illness and death, said Gili Regev-Yochay, one of the authors of the study. Such studies will help assess risk levels for various groups and the measures needed to protect them, the researcher said.

Antibody levels were found to be lower in older people than in younger, and in immunosuppressed individuals compared to the healthy population, according to the study from Sheba Medical Center in Ramat Gan. Men's antibody counts were lower than those of women both at their peak and at the end of the study.
      Read More...
Syringe

Study shows COVID vaccine does NOT reduce infection as countries with higher vaccination have more cases

David Heller
America's Frontline Doctors
Wed, 06 Oct 2021 11:52 UTC
VacciNation
In a comparison of 68 countries and 2,947 counties in the U.S., a new study concludes that jurisdictions with high vaccination rates do not have lower infection rates. A recent study just published in the European Journal of Epidemiology demonstrated that vaccination rates did not have an effect on new cases of COVID in the first week of September.
      Read More...
Arrow Down

Covid UK: Cases drop week-on-week for fifth day in a row as deaths fall to 33

Emily Craig
The Daily Mail
Mon, 04 Oct 2021 17:58 UTC
Britain covid cases drop September 2021
Covid cases in the UK have dropped for a fifth day in a row, official figures revealed today. Another 35,077 positive tests were recorded across Britain, down 7.6 per cent on last Monday.

The decline follows nearly two weeks of rising infections, fuelled by millions of pupils returning to classrooms last month.

Meanwhile, 33 deaths were registered among people who tested positive for the virus in the last 28 days. It marks a week-on-week drop of 17.5 per cent. No Covid hospitalisation figures were provided for the UK as a whole — but that trend has also been falling.

The fatality figure lags several weeks behind infections because of how long it can take for infected patients to become seriously ill.
      Read More...
Red Flag

Patients with 'red flag' cancer symptoms not referred for urgent investigation in 6 out of 10 cases


Medical Xpress
Mon, 04 Oct 2021 00:01 UTC
pink ribbon breast cancer
Six out of ten patients who show common "alarm" symptoms for cancer are not referred for urgent investigation, a largescale new study has revealed.

The research, led by the University of Exeter working with University College London, and funded by Cancer Research UK, found that a significant number of the patients who were not referred went on to develop cancer within a year of their GP consultation.

One in two people are affected by cancer in their lifetimes, and cancer accounts for nearly 10 million deaths each year worldwide. Early diagnosis is known to be a major factor in saving lives.
      Read More...
SOTT Logo Radio

Objective:Health - The Spartacus Letter


Sott.net
Tue, 05 Oct 2021 00:00 UTC
O:H header
On September 24th a mysterious PDF was uploaded online that quickly went viral on social media. Dubbed "The Spartacus Letter", it's a document that outlines almost everything about Covid, from disease function and treatment to revealing the vast criminal conspiracy behind the Covid outbreak. The author of the paper is unknown (although the paper references 'we', indicating there is a group behind it). They make no claim as to their qualifications, although many commentators have said the authors are clearly scientists of some kind, given the level of education and experience clearly evident.

Much of what is stated in the Spartacus Letter is indisputable medical fact about the disease itself, the treatment protocols (successful and unsuccessful), the vaccines, but it also goes into great detail about the criminal conspiracy behind the virus and the thwarting of effective medical treatments.

The authors state the information in the Spartacus Letter is not new - indeed, they say this information has been known for over a year in medical and scientific communities. However, it is extensive and most of those reading it will undoubtedly find something they didn't previously know. Despite its length, and despite the fact that it is unlikely to be entirely true from beginning to end, it is well worth the read.

Join us on this episode of Objective:Health as we discuss the Spartacus Letter.

You can find the letter here: https://www.sott.net/article/458947-The-Spartacus-covid-letter-thats-going-viral

and here: https://mega.nz/file/HZNmyRKB#xF15FrsAEZkwBPi4tdUP5toBBqeRHDJJAHzZt6Hg_Qg


Also check us out on Brighteon!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥LBRY: https://lbry.tv/@objectivehealth:f
♥Odysee: https://odysee.com/@objectivehealth:f

And you can check out all of our previous shows (pre YouTube) here:

♥https://docs.google.com/spreadsheets/d/16H-nK-N0ANdsA5JFTT12_HU5nUYRVS9YcQh331dG2MI/edit?usp=sharing

Running Time: 00:39:19

Download: MP3 — 36 MB

      Read More...
Health

Prescribed blood thinners can help reduce hospitalizations related to COVID-19

University of Minnesota Medical School
Medical Xpress
Sat, 02 Oct 2021 09:15 UTC
red blood cells
The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and mortality. To find ways to decrease clotting related to COVID-19, researchers from the University of Minnesota and Basel University in Switzerland looked at reducing hospitalizations by using prescribed blood thinners.

"We know that COVID-19 causes blood clots that can kill patients," said lead author Sameh Hozayen, MD, MSC, an assistant professor of medicine at the U of M Medical School. "But, do blood thinners save lives in COVID-19? Blood thinners are medications prescribed to prevent blood clots in patients with a prior blood clot in their lungs or legs. They also prevent blood clots in the brain secondary to abnormal heart rhythms, like atrial fibrillation. Blood thinners are the standard of treatment in these diseases, which is why we looked at data to see if it impacted hospitalizations related to COVID-19."

"We already know that overwhelmed hospitals have a higher risk for death among their patients, so reducing hospitalization may have a positive impact during a COVID-19 surge," Hozayen said.

Published in Lancet's Open Access EClinical Medicine, the study found that:
  • patients on blood thinners before having COVID-19 were admitted less often to the hospital, despite being older and having more chronic medical conditions than their peers;
  • blood thinners — regardless of if they are being used before being infected with COVID-19 or started when admitted to the hospital for treatment of COVID-19 — reduce deaths by almost half; and,
  • hospitalized COVID-19 patients benefit from blood thinners regardless of the type or dose of the medication used.
      Read More...
Health

Delirium recorded in up to 80% of Covid-19 ICU patients

Carly Cassella
Science Alert
Thu, 23 Sep 2021 12:00 UTC
psychology delirium
© yngsa/Getty Images
Patients with COVID-19 who have been admitted to the intensive care unit are very likely to experience unusually persistent delirium, according to emerging research.

Delirium is a medical term used to describe confused thinking and reduced awareness of surroundings - a not uncommon state of mind for the sickest hospitalized patients.

As it turns out, severe cases of COVID-19 are enough to trigger something similar. In fact, initial investigations have suggested delirium occurs in up to 80 percent of ICU patients with COVID-19, possibly as a result of loss of oxygen to the brain or widespread inflammation.

Comment: Whilst it appears there are a number of factors that may have contributed to the rise in delirium, as noted n the article, numerous studies have shown that suffering from Covid does have an impact on the brain and neurological functioning. In addition, the experimental RNA vaccines have also been found to expose one to an increased risk of schizophrenia: RNA Vaccines, Obedience and Eugenics

See also:

      Read More...
Amazon Smile
Revolt! T-shirts